Xarelto Paediatric VTE PASS Drug Utilization Study: An observational, longitudinal, multi-source drug utilization safety study to evaluate the drug use patterns and safety of rivaroxaban oral suspension in children under two years with venous thromboembolism (XAPAEDUS)

10/05/2023
04/12/2025
EU PAS number:
EUPAS46800
Study
Planned
Documents
Study protocol
Initial protocol
English (735.21 KB - PDF) View document
Study results
Study report
Study report
English (191.38 KB - PDF) View document
Other information